Contineum Therapeutics, Inc.

US$9.52As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTNMHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (17.77%)
Div yield —
ROE (29.80%)
Biotechnology
Beta (5Y) 1.07
PE TTM —
TSR TTM (13.53%)
Mkt cap US$373.8M
ROIC (20.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
14.43%
209.72%
Hold 7|9|4|3|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.18
0.18
0.17
41.65%
32.07%
24.47%
10.11%
Revenue$M
24.09
24.41
24.10
24.57
2.57%
2.14%
(1.07%)
2.93%
Peers (US$373.8M)
Cap (US$)
PE
374.4M
39.28x
Capital
TTM
5Y
10Y
Leveragex
0.405
(0.052)
(0.046)
EBIT/Intx
1.227
0.053
0.053
Own earn%
(221.25)
128.09
117.40
Sh yield%
37.07
24.38
24.99
Owners
Insiders/Inst%
6.39
71.86
Short interest%
5.69
SBC / revenue%
4.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
6–11
$1 testx
0.1
Incr. ROIC%
2